UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Science (American Association for the Advancement of Science), ISSN 0036-8075, 6/2012, Volume 336, Issue 6088, pp. 1534 - 1541
Receptors | Inoculation | Experimental infection | Disease transmission | Pandemics | REPORTS | Viruses | Orthomyxoviridae | Ferrets | Genetic mutation | Amino acid substitution | particle size | Influenza virus A H5N1 | antiviral resistance | hemagglutination test | virus replication | virus transmission | site directed mutagenesis | virus particle | Influenza virus A | animal experiment | nose smear | review | animal tissue | virus isolation | DNA modification | nonhuman | sequence analysis | amino acid substitution | priority journal | ferret | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Immune Sera | Reassortant Viruses - pathogenicity | Influenza A Virus, H5N1 Subtype - physiology | Poultry | Receptors, Virus - metabolism | Air Microbiology | Humans | Virulence | Molecular Sequence Data | Influenza A Virus, H5N1 Subtype - genetics | Virus Shedding | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Respiratory System - virology | Female | Influenza, Human - virology | Oseltamivir - pharmacology | Disease Models, Animal | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Reverse Genetics | Antiviral Agents - pharmacology | Mutagenesis, Site-Directed | RNA Replicase - genetics | Viral Proteins - chemistry | Sialic Acids - metabolism | Viral Proteins - genetics | Influenza, Human - epidemiology | Containment of Biohazards | Influenza A Virus, H5N1 Subtype - drug effects | Influenza in Birds - epidemiology | Influenza, Human - transmission | Hemagglutinin Glycoproteins, Influenza Virus - metabolism | Animals | Orthomyxoviridae Infections - transmission | Virus Replication | RNA Replicase - chemistry | Influenza in Birds - virology | Influenza A Virus, H5N1 Subtype - pathogenicity | Mutation | Serial Passage | Orthomyxoviridae Infections - virology | Amino Acid Substitution | Avian influenza | Diseases and pests | Physiological aspects | Development and progression | Research | Animal diseases | Amino acids | Avian flu | Small mammals | Index Medicus | Polymerase | Human | Proteins | Influenza | Droplets | Genetic modification
Journal Article
Nature, ISSN 0028-0836, 10/2005, Volume 437, Issue 7062, pp. 1108 - 1108
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Humans | Influenza A virus - genetics | Neuraminidase - genetics | Acetamides - pharmacology | Influenza A Virus, H5N1 Subtype | Sialic Acids | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Zanamivir | Acetamides - therapeutic use | DNA Mutational Analysis | Neuraminidase - chemistry | Polymerase Chain Reaction | Inhibitory Concentration 50 | Adult | Female | Influenza, Human - virology | Influenza, Human - drug therapy | Influenza A virus - growth & development | Neuraminidase - metabolism | Guanidines | Influenza A virus - isolation & purification | Influenza, Human - transmission | Ferrets | Mutation - genetics | Oseltamivir | Drug Resistance, Viral - genetics | Acetamides - supply & distribution | Adolescent | Neuraminidase - antagonists & inhibitors | Influenza A virus - drug effects | Influenza, Human - prevention & control | Acetamides - administration & dosage | Pyrans | Index Medicus
Journal Article
Antiviral research, ISSN 0166-3542, 05/2013, Volume 98, Issue 2, pp. 297 - 304
Resistance | Oseltamivir | Amantadine | H5N1 influenza virus | Neuraminidase inhibitors | Zanamivir | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antiviral Agents - pharmacology | Humans | Drug Resistance, Viral | Viral Proteins - genetics | Birds | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Phylogeny | Influenza A Virus, H5N1 Subtype - isolation & purification | Animals | Influenza in Birds - virology | Influenza A Virus, H5N1 Subtype - pathogenicity | Influenza, Human - virology | Virus diseases | Avian influenza | Avian influenza viruses | Index Medicus | zanamivir | neuraminidase inhibitors | oseltamivir | resistance
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 10/2005, Volume 11, Issue 10, pp. 1515 - 1521
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Antiviral Agents - therapeutic use | Poultry | Humans | Influenza, Human - epidemiology | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Influenza in Birds - epidemiology | Phylogeny | Poultry Diseases - virology | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Genetic Variation | Asia - epidemiology | Phenotype | Animals | Chickens | Influenza in Birds - virology | Influenza, Human - virology | Neuraminidase - antagonists & inhibitors | Influenza Vaccines | Influenza, Human - drug therapy | Poultry Diseases - epidemiology | Evolution, Molecular | Avian influenza | Causes of | Health aspects | Index Medicus | Influenza in Birds | Influenza A Virus, H5N1 Subtype | Emerging diseases | Life Sciences | Animal biology | Antiviral Agents | Hemagglutinin Glycoproteins, Influenza Virus | Virology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Veterinary medicine and animal Health | Asia | Influenza, Human | Neuraminidase | Poultry Diseases | Adamantane | hemagglutinin | M2 protein | Avian | Research | NA protein | Influenza A Virus | Oseltamivir | molecular Evolution | virology | Influenza
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 11/2012, Volume 206, Issue 9, pp. 1359 - 1366
Respiratory insufficiency | Corticosteroids | Influenza A virus | Antivirals | Patient care | Viruses | Orthomyxoviridae | Infections | H5N1 subtype influenza A virus | Symptoms | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Infectious diseases | Medical sciences | Humans | Middle Aged | Child, Preschool | Respiratory Insufficiency - virology | Infant | Male | Influenza, Human - complications | Secondary Prevention | Young Adult | Influenza, Human - mortality | Adult | Female | Influenza, Human - virology | Influenza, Human - drug therapy | Child | Oseltamivir - pharmacology | Antiviral Agents - pharmacology | Respiratory Insufficiency - mortality | Treatment Outcome | Influenza A Virus, H5N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Oseltamivir - administration & dosage | Adolescent | Survival Analysis | Aged | Oseltamivir phosphate | Usage | Prognosis | Research | Drug therapy | Influenza | Index Medicus | Abridged Index Medicus
Journal Article
Virology (New York, N.Y.), ISSN 0042-6822, 11/2020, Volume 550, pp. 51 - 60
Heterosubtypic immunity | M2 extracellular domain epitope | Neuraminidase epitope | Cross protection | Recombinant chimeric influenza virus | Life Sciences & Biomedicine | Science & Technology | Virology | Influenza A Virus, H1N1 Subtype - immunology | Orthomyxoviridae Infections - prevention & control | Recombinant Fusion Proteins - immunology | Influenza Vaccines - administration & dosage | Viral Matrix Proteins - genetics | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Vaccines, Inactivated | Cross Protection | Neuraminidase - genetics | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Influenza A Virus, H5N1 Subtype - genetics | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H3N2 Subtype - genetics | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Influenza A Virus, H9N2 Subtype - immunology | Neuraminidase - immunology | Epitopes - immunology | Reassortant Viruses - immunology | Immunity, Cellular - drug effects | Vaccination - methods | Female | Influenza A Virus, H1N1 Subtype - genetics | Antibodies, Viral - biosynthesis | Influenza A Virus, H9N2 Subtype - genetics | Influenza A Virus, H9N2 Subtype - drug effects | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Influenza A Virus, H3N2 Subtype - immunology | Animals | Influenza Vaccines - genetics | Influenza A Virus, H5N1 Subtype - immunology | Influenza Vaccines - biosynthesis | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Epitopes - chemistry | Mice | Mice, Inbred BALB C | Viral Matrix Proteins - immunology | Orthomyxoviridae Infections - virology | Orthomyxoviridae Infections - immunology | Index Medicus
Journal Article
Viruses, ISSN 1999-4915, 03/2020, Volume 12, Issue 3, p. 304
Life Sciences & Biomedicine | Science & Technology | Virology | Cell Line | Hemagglutinin Glycoproteins, Influenza Virus - chemistry | Antiviral Agents - pharmacology | Cell Survival | Humans | Molecular Conformation | Models, Molecular | Neutralization Tests | Influenza A Virus, H5N1 Subtype - drug effects | Structure-Activity Relationship | Enzyme Activation - drug effects | Chick Embryo | Hemagglutinin Glycoproteins, Influenza Virus - metabolism | Virus Internalization | Dose-Response Relationship, Drug | Hemagglutination Inhibition Tests | Animals | Antiviral Agents - chemistry | Protein Binding | Molecular Structure | Influenza A Virus, H5N1 Subtype - metabolism | Binding Sites | Index Medicus | h5n1 subtype avian influenza virus | chlorogenin 3-o-β-chacotrioside derivatives | antiviral mechanism | hemagglutinin
Journal Article
Nature, ISSN 0028-0836, 09/2006, Volume 443, Issue 7107, pp. 45 - 49
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fundamental and applied biological sciences. Psychology | Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains | Antiviral agents | Microbiology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Virology | Antibiotics. Antiinfectious agents. Antiparasitic agents | Influenza A Virus, H5N1 Subtype - enzymology | Humans | Neuraminidase - genetics | Acetamides - pharmacology | Influenza A Virus, H5N1 Subtype - classification | Influenza A Virus, H5N1 Subtype - genetics | Antiviral Agents - metabolism | Antiviral Agents - chemistry | Drug Design | Neuraminidase - chemistry | Influenza in Birds - drug therapy | Binding Sites | Neuraminidase - classification | Antiviral Agents - pharmacology | Birds - virology | Models, Molecular | Influenza A Virus, H5N1 Subtype - drug effects | Mutation - genetics | Acetamides - metabolism | Oseltamivir | Drug Resistance, Viral - genetics | Animals | Influenza in Birds - virology | Neuraminidase - antagonists & inhibitors | Protein Conformation | Enzymes | Disease transmission | Pandemics | Inhibitor drugs | Avian flu | Crystal structure | Index Medicus
Journal Article
Trends in immunology, ISSN 1471-4906, 2009, Volume 30, Issue 12, pp. 574 - 584
Allergy and Immunology | Life Sciences & Biomedicine | Immunology | Science & Technology | Influenza A Virus, H1N1 Subtype - immunology | Tumor Necrosis Factor-alpha - metabolism | Influenza, Human - pathology | Orthomyxoviridae Infections - physiopathology | Humans | Influenza A Virus, H3N2 Subtype - pathogenicity | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza, Human - epidemiology | Immunity, Innate | Influenza A Virus, H3N2 Subtype - immunology | Respiratory Distress Syndrome, Adult - immunology | Animals | Influenza A Virus, H5N1 Subtype - immunology | Interferons - metabolism | Influenza A Virus, H5N1 Subtype - pathogenicity | Mice | Influenza, Human - physiopathology | Orthomyxoviridae Infections - immunology | Influenza, Human - immunology | Avian influenza | Influenza viruses | Immune response | Health aspects | Analysis | Infections | Pandemics | Mutation | Respiratory distress syndrome | Genes | Index Medicus | Influenza A Virus, H3N2 Subtype | Respiratory Distress Syndrome, Adult | Interferons | Influenza A Virus, H5N1 Subtype | Tumor Necrosis Factor-alpha | Virology | Life Sciences | Microbiology and Parasitology | Influenza, Human | Influenza A Virus, H1N1 Subtype | Orthomyxoviridae Infections | influenza | cytokine | H5N1 | macrophage | pandemic | innate immune response
Journal Article